STROKE TeleQOL: Quality of Life After Stroke Using a Telemedicine-based Stroke Network
Study Details
Study Description
Brief Summary
To study the effect of a telemedicine model of stroke care on patient-based outcomes.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
Detailed Description
Approximately 750,000 patients suffer from ischemic stroke (AIS) annually in the United States. AIS is a a leading cause of long-term disability and the third-leading cause of mortality. Effective therapies exist to ameliorate the disability associated with AIS, but implementation of these therapies is time-sensitive. Currently, there is a shortage in health care professionals with expertise in the treatment of stroke and such expertise tends to be concentrated in large community-based or academic medical centers. To respond to this shortage, stroke networks are being organized in a "hub-and-spoke" model to facilitate the rapid delivery of time-sensitive interventions such as intravenous (i.v.) tissue plasminogen activator (tPA) or rapid evaluation for AIS. Some networks are also using telemedicine to facilitate this approach and bring the needed expertise via robotic tele-presence (RTP). Though the accuracy of stroke diagnosis and i.v. tPA utilization may be higher in RTP based networks, the impact of this model on patient's outcomes has been difficult to elucidate. To this end, meaningful validated outcome assessments are crucial to understand the impact of stroke interventions including telemedicine or RTP based networks. The objective of this study is to translate evidence-based practice of healthcare, patient-centered outcome assessments, and patient-family perceptions of delivery of care into meaningful data. This will aid in the validation of the role of interventions such as "hub-and-spoke" RTP based models in stroke care.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Exposed AIS patients evaluated through RTP and who receive i.v. tPA |
Drug: Alteplase
Intravenous (i.v.) tPA per the standard of care
Other Names:
|
| Un-exposed AIS patients evaluated through RTP and who do not receive i.v. tPA |
Outcome Measures
Primary Outcome Measures
- HRQoL [6 months]
Health Related Quality of Life
Secondary Outcome Measures
- mRS [6 months]
Modified Rankin Scale
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients with suspected acute ischemic stroke (AIS)
-
Age >17 years
Exclusion Criteria:
-
Hemorrhagic strokes (ICH or SAH)
-
Transient ischemic attacks (TIA)
-
Trauma
-
Inability to obtain informed consent
-
Participation in another study
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | United States | 19107 |
Sponsors and Collaborators
- Thomas Jefferson University
- Genentech, Inc.
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 15D.044